Synthetic Chemical Biology Core

合成化学生物学核心

基本信息

批准号：
10414318
负责人：
Jon A Tunge
金额：
$ 22.95万
依托单位：
UNIVERSITY OF KANSAS LAWRENCE
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-07-01 至 2027-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10414318
关键词：
Address Affinity Benchmarking Biological Biology Biomedical Research Biotin Centers of Research Excellence Chemicals Chemistry Client Collection Communicable Diseases Communities Core Facility Custom DNA Sequencing Facility Development Discipline Disease Pathway Evaluation Faculty Fluorescent Probes Funding Generations Genes Goals Imaging Device In Vitro Isotopes Kansas Lead Mission Molecular Analysis Molecular Probes Organic Chemistry Pathology Pathway interactions Peptides Pharmaceutical Chemistry Pharmacology Phase Physiology Pilot Projects Property Proteins Research Research Infrastructure Research Personnel Services Synthesis Chemistry Techniques Therapeutic Validation Work base biological systems design drug development drug discovery fluorophore genome sequencing in vitro Bioassay in vivo in vivo imaging innovation interest nanofabrication novel outreach preclinical study programs screening small molecule success tool

项目摘要

PROJECT SUMMARY – CORE C The Synthetic Chemical Biology Core (SCB) was established in July 2016 from the merger of the Center for Molecular Analysis of Disease Pathways (CMADP) Molecular Probes Core with the newly established Chemical Biology of Infectious Disease (CBID) Medicinal Chemistry Core. The synthetic capabilities of the SCB will fulfill the specific aims of both COBRE centers. The mission for the SCB in Phase 3 is to provide CMADP-affiliated junior faculty, as well as other investigators in the state of Kansas, with novel molecular probes as pharmacological tools for in vitro or in vivo elucidation of particular pathways. The SCB will also work towards achieving self-sustainability beyond Phase 3. The Core will offer expert design and synthesis of small molecule and peptide molecular probes, with an emphasis on the generation of fluorescent and other affinity tagged molecules. The SCB will function synergistically with other CMADP-funded Core facilities, including the Genome Sequencing Core, to identify genes that impact functions of probes in vivo, and the KU Nanofabrication Facility, to develop devices for imaging and chemical analysis. This integration is designed to empower faculty to use chemical biology approaches to investigate biological problems. The specific aims that will be addressed by the SCB in Phase 3 are: (1) Provide enabling small molecules of interest to COBRE investigators and other clients; (2) Provide synthesis of conventional and specialized peptides to investigators; (3) Provide outreach, administrative, and fiscal support necessary to manage the above activities both in the context of COBRE projects and to offer services to the larger Kansas research community (4) To continue developing a critical mass of core lab users so that the facility becomes a self-sustaining, integral part of the biomedical research infrastructure in the state of Kansas.

项目摘要 - 核心C 合成化学生物学核心（SCB）于2016年7月从合并中心合并疾病途径（CMADP）分子探针的分子分析与新建立的化学传染病（CBID）药物化学核心的生物学。 SCB的合成能力将实现这两个山核桃中心的具体目的。 SCB在第3阶段的任务是提供与CMADP相关的初级教师以及堪萨斯州的其他研究人员，具有新的分子问题用于体外或体内特定途径的药理工具。 SCB也将努力超越第3阶段的自我可持续性。核心将提供小分子的专家设计和合成和胡椒分子问题，重点是荧光和其他亲和力的产生分子。 SCB将与其他CMADP资助的核心设施协同起作用，包括基因组测序核心，以确定影响体内问题功能的基因以及ku纳米制造设施，开发用于成像和化学分析的设备。该集成旨在使教师使用化学生物学方法来研究生物学问题。 SCB将在第3阶段解决的具体目的是：（1）提供启用的小分子毛茸茸的调查员和其他客户的兴趣；（2）提供常规和专业宠物的合成给调查人员；（3）提供管理上述必要的外展，行政和财政支持在山脉项目的背景下进行活动，并为堪萨斯州较大的研究社区提供服务（4）继续开发大量的核心实验室用户，以便该设施成为自我维持的，不可或缺的堪萨斯州生物医学研究基础设施的一部分。